Primary regulatory
Medical product alert: falsified Ozempic
WHO alert about falsified semaglutide products identified in multiple countries.
World Health OrganizationPublished 2024-06-19Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- World Health Organization
- Source type
- Primary regulatory
- Registry ID
who-falsified-semaglutide-alert-2024
Source usage
Not yet linked from a public content page
This record may be retained for an upcoming review or for internal source normalization.
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.